Xplore lab has received a Clinical Translation Impact Grant in the amount of $99,000 from the Canadian Stem Cell Network to continue their work on pre-clinical optimization of umbilical cord-derived perivascular cells for neonatal lung injury.
This study will allow us to test the therapeutic efficacy of these cell types in a unique experimental model available in only one facility in the world.